Student, 22, brushed off common symptoms as a sinus infection before life-changing cancer diagnosis
Breeze Hunter has revealed how she received the life-changing diagnosis after experiencing headaches for months on end, as well as persistent pressure in her nose.
She had shared her concerns with a medic, who informed her she had 'a lot of fluid' in her ears which was causing her headaches and that she likely had a 'sinus infection'.
When she headed back to the doctors a few months later still complaining of the continuing headaches as well as feeling 'very weak and fatigued', Breeze underwent some blood tests.
The Texas A&M University student was informed that she was very anaemic - meaning her body was not producing enough healthy red blood cells - which rang alarm bells, and she was encouraged to take herself to hospital.
Breeze headed to the University of Texas Medical Branch Hospital in her hometown of League City, Texas, and underwent further testing, where it emerged she was dealing with something a lot more sinister than a sinus infection.
"I had many people coming in and saying, 'It's looking like a sign of leukaemia, but we'll keep testing because it could be a bunch of other things'," she told Today.com.
"I freaked out. I had no idea what leukaemia was. I was like, 'am I going to survive this? Or is it treatable?'"
Her worst fears came true when doctors at the MD Anderson Cancer Center then confirmed she had acute myeloid leukaemia (AML), which the NHS describe as an 'aggressive cancer of the monocyte or granulocyte cells'.
It's considered a rare form of the disease, and around 3,100 people in the UK are diagnosed with it each year. Symptoms tend to progressively get worse.
Signs of AML can include looking pale or 'washed out', feeling tired or weak, breathlessness, frequent infections, unusual and frequent bruising or bleeding, and unexplained weight loss.
Breeze's treatment quickly got underway and she first had a bone marrow aspiration, a procedure where doctors take a sample of the liquid part of your bone marrow to be sent off for testing.
She also had a spinal tap, which is also known as a lumbar puncture, which is where a sample of cerebrospinal fluid is taken to be sent off for analysis.
Doctors determined it would be best for her to stay in hospital as they tackled the AML head on by giving her chemotherapy infusions, with a pill for a week straight as part of a clinical trial.
Medics saw a vast improvement in her health within 21 days, and Breeze was given a second round of the trial treatment.
"I was supposed to get at least six rounds," the college student said. "The chemo worked so well I only had to do two."
After 11 rounds of radiation and another blast of chemotherapy, Breeze then underwent a stem cell transplant. Thankfully, her younger brother Roy, 21, was a perfect match and was able to be her donor.
Reflecting on her intense treatment, the young woman explained: "I got a radiation/chemo burn all over my body, which was very very painful and I was pretty much burnt all over.
"Probably towards the end, I was over it. I was like, 'I can't do this. This is too much'. It was very hard at times but God's watching me. So, I knew I was going to be okay."
Breeze remained in hospital for over a month as she recovered.
Dr Courtney DiNardo, a professor at The University of Texas MD Anderson Cancer Center with an expertise in of leukaemia, said Breeze is now 'doing fantastic'.
"Being a college student in the prime of your life getting dealt a life-threatening cancer diagnosis, I can only imagine how life altering and depressing it could be," he said.
"But she's always had such a beautiful spirit and good attitude."
Breeze will continue with chemotherapy treatment for the next year to be on the safe side - but says she is 'so excited' to make the most of her second chance at life.
"Cancer is very, very scary," the student said. "If you ever have any side effects like headaches, you're losing weight, you have bruises on you, anything like that, go to the doctor and get blood work done...it can't hurt you and it just tells you if something is wrong."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
a day ago
- Fox News
Wearable hydration monitor could help prevent heatstroke, scientists say
A new wearable sensor could help people avoid the dangers of dehydration by alerting them when their bodies need more water. Developed by researchers at the University of Texas, the non-invasive device continuously measures hydration levels in real time and wirelessly transmits the data to a smartphone, according to an SWNS report. "Dehydration is a silent threat that affects millions of people every day," said Professor Nanshu Lu of the University of Texas at Austin, who led the study. "Our wearable sensor provides a simple, effective way to monitor hydration levels in real time, empowering individuals to take proactive steps to stay healthy and perform at their best," she added, per SWNS. The sensor uses a method called bioimpedance, which sends a small, safe electrical current through the body via strategically placed electrodes. The current's flow depends on how hydrated the tissues are — hydrated tissue allows the current to pass easily, while dehydrated tissue resists the flow, according to SWNS. "Arm bioimpedance is not only sensitive to hydration changes, but also aligns closely with whole-body hydration measurements," said study co-author Dr. Matija Jankovic, a post-doctoral researcher in Professor Lu's lab. "Dehydration is a silent threat that affects millions of people every day." "This means the sensor can be a reliable surrogate for tracking hydration levels, even during everyday activities like walking, working or exercising," Jankovic added. To validate the device, the research team conducted multiple experiments, including a diuretic-induced dehydration study and a 24-hour real-life trial. Participants were given medication to promote fluid loss. Their hydration levels were monitored via the wearable and compared to urine samples. The device showed a strong correlation between changes in arm bioimpedance and total body water loss, SWNS reported. The findings were published in the Proceedings of the National Academy of Sciences. The new sensor could offer an accessible and wearable alternative to traditional hydration tracking methods, such as urine or blood analysis, which are invasive, time-consuming and impractical, the researchers noted. Hydration is known to be essential for regulating body temperature, maintaining organ function and supporting many other vital processes. Even mild dehydration can impair concentration and performance, while severe dehydration may lead to serious health problems like heatstroke, kidney stones and cardiovascular issues, according to experts. Beyond everyday use, the researchers believe the technology could benefit patients with chronic dehydration, kidney disease or heart conditions. Athletes, too, could use the wearable to stay safe and perform optimally, especially in hot weather. While the current model tracks relative hydration changes, Professor Lu said the team aims to develop reference data for absolute hydration levels. They are also exploring more advanced wearable formats, like breathable electronic tattoos or sweat-absorbing patches, to enhance comfort during long-term use. For more Health articles, visit "This is just the beginning," Professor Lu said, per the SWNS report. "Our goal is to make simple hydration monitoring accessible to everyone."
Dominion Post
2 days ago
- Dominion Post
Larry K. Pickering
Dr. Larry K. Pickering, a distinguished leader in pediatric infectious disease and a dedicated mentor, passed away Tuesday, July 1, 2025, in San Diego, Calif. He was 81.A trailblazer in medical education, research, and public health, Dr. Pickering played a pivotal role in shaping immunization policy in the United States and around the world. His contributions profoundly impacted the health and lives of countless children in 1944, Dr. Pickering earned his medical degree from West Virginia University School of Medicine in 1970. He completed a pediatric residency and an infectious disease fellowship at Washington University School of Medicine, launching a remarkable career devoted to protecting children from infectious his career, Dr. Pickering held academic and leadership roles at the University of Texas-Houston, MD Anderson Cancer Center, Emory University, Eastern Virginia Medical School, and the Centers for Disease Control and Prevention (CDC). He served on the Advisory Committee on Immunization Practices (ACIP) and was editor of the American Academy of Pediatrics' Red Book for three editions – a definitive resource on pediatric infectious Pickering is survived by his beloved wife, Mimi; their children, Maggie and Andy; and three grandchildren, Kenan, Edie and Mae. He is also survived by his sister, Susan; brother-in- law, Mike; and two nephews, Lucas and was known for his sharp wit and infectious sense of humor, and he was willing to bet on almost anything. His granddaughters remember him as an inspiring and kind-hearted man who always had a joke to share. A master card player, he usually won, and graciously accepted checks from those who owed was deeply proud of his West Virginia roots and his alma mater, West Virginia University. He established a lasting scholarship there to support future generations of medical students, endowed Pickering Chair, and the Hogan Lecture Series.A memorial service will be held in September 2025 to honor his enduring legacy in pediatric infectious disease and public health. In lieu of flowers, the family requests donations to the West Virginia University Pediatric Department or Alzheimer's San Diego.
Newsweek
3 days ago
- Newsweek
Tiny 'Flowers' Offer New Hope Against Alzheimer's and Parkinson's
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Tiny, metallic, flower-shaped nanoparticles may offer fresh hope for patients with neurodegenerative diseases like Alzheimer's and Parkinson's. This is the conclusion of researchers from Texas A&M University, who found that the so-called nanoflowers can protect and heal brain cells. The do this by promoting the health and turnover of mitochondria—the oft-dubbed "powerhouses of the cell" which are responsible for turning food into energy. While this process is essential for life, the mitochondria also produce waste in the process—including so-called "reactive oxygen species"—which can damage cells. The finding could pave the way for new treatments for neurological diseases that address the underlying root causes—in this case mitochondrial health and oxidative stress—instead of just managing symptoms. "We expect that our drug can reverse neuronal damage and consequently reverse neurodegeneration," study lead and biochemist professor Dmitry Kurouski told Newsweek. Alzheimer's is the most common neurodegenerative disease with Parkinson's coming in second—and promising new treatments are much sought after. In fact, more than seven million Americans are living with Alzheimer's, a figure projected to rise to nearly 13 million by 2050, according to the Alzheimer's Association. Meanwhile, around 1.1 million people in the U.S. are living with Parkinson's, expected to rise to 1.2 million by 2030, according to Parkinson's Foundation. Alongside potentially helping combat Alzheimer's and Parkinson's, Kurouski said, "it is important to mention that similar reversing effects could be expected in other pathologies including acute brain and spinal cord injuries." Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Lacheev / iStock / Getty Images Plus / Journal of Biological Chemistry In their study, Kurouski and colleagues explored—in a petri dish in the lab—how nanoflowers affect both the brain's nerve cells, or 'neurons', and the star-shaped 'astrocytes' that support them. Within 24 hours of treatment, the team saw a "dramatic" drop in the levels of ROS, accompanied by signs of improved mitochondrial function. "Even in healthy cells, some oxidative stress is expected. But the nanoflowers seem to fine-tune the performance of mitochondria, ultimately bringing the levels of their toxic byproducts down to almost nothing," Kurouski explained. Having assessed the effects on individual cells, the researchers next tested the impact of the nanoflowers on whole creatures—specifically a species of worm, C. elegans, which is commonly used as a model organism in neurological research. The team found that, on average, worms treated with one specific flavor of nanoflower survived for days longer than their untreated counterparts (which typically live for around 18 days) and were less likely to die during the early stages of their lives. "These nanoflowers look beautiful under a microscope, but what they do inside the cell is even more impressive," Kurouski said in a statement. "By improving the health of brain cells, they help address one of the key drivers of neurodegenerative diseases that have long resisted therapeutic breakthroughs." With more research needed before clinical trials could be conducted on humans, Kurouski says he plans to undertake further studies in more complex animal models. The team are also exploring practical concerns towards clinical applications. "We are currently working on finding the best way to administrate the drug. We anticipate that internasal spray will be the best solution," Kurouski said. The biochemist stressed that he is keen to make sure the nanoflowers are safe, effective and have clear mechanism of action—but, he concluded, he thinks they could be a "new class of therapeutics" with "incredible potential." Do you have a health story to share with Newsweek? Do you have a question about the study? Let us know via health@ Reference Mitchell, C. L., Matveyenka, M., & Kurouski, D. (2025). Neuroprotective properties of transition metal dichalcogenide nanoflowers alleviate acute and chronic neurological conditions linked to mitochondrial dysfunction. Journal of Biological Chemistry, 301(5).
